Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalayoglu

Showing results (161-170 of 212) with videos related to

Pageof 22
Sort By:
Surgery|October 3, 2000
Liver transplantation from controlled non-heart-beating donorsA M D'alessandro, R M Hoffmann, S J Knechtle, et al.
Bone Marrow Transplantation|May 16, 2003
Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centersM Beksac, H Celebi, D Sargín, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 4, 2024
Efficacy of Low-Density Lipoprotein Cholesterol Apheresis in the Treatment of Familial Hypercholesterolemia: Single Center ExperienceHulya Hacisahinogullari, Gamze Bilik Oyman, Ummu Mutlu, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 30, 2005
Liver transplantation for biliary atresia: 19-year, single-center experienceL Thomas Chin, Anthony M D'Alessandro, Stuart J Knechtle, et al.
Transplantation|January 1, 1992
The effect of donor age, recipient age, and HLA match on immunologic graft survival in cadaver renal transplant recipientsJ D Pirsch, A M D'Alessandro, H W Sollinger, et al.
Transplantation|February 27, 1995
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter TrialS V McDiarmid, R W Busuttil, N L Ascher, et al.
Surgery|October 1, 1992
Liver transplantation for alcoholic liver diseaseS J Knechtle, M F Fleming, K L Barry, et al.
Transplantation|April 1, 1993
Risk factors for primary dysfunction after liver transplantation--a multivariate analysisR J Ploeg, A M D'Alessandro, S J Knechtle, et al.
Clinical Transplants|January 1, 1989
Cadaveric renal transplantation in the cyclosporine and OKT3 eras: an update of the University of Wisconsin-Madison experienceA M D'Alessandro, D F Lorentzen, J D Pirsch, et al.
Transplantation Proceedings|April 26, 2005
Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimenS Florman, R Alloway, M Kalayoglu, et al.
Pageof 22

Showing results (161-170 of 212) with videos related to

Sort By:
Pageof 22
Surgery|October 3, 2000
Liver transplantation from controlled non-heart-beating donorsA M D'alessandro, R M Hoffmann, S J Knechtle, et al.
Bone Marrow Transplantation|May 16, 2003
Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centersM Beksac, H Celebi, D Sargín, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 4, 2024
Efficacy of Low-Density Lipoprotein Cholesterol Apheresis in the Treatment of Familial Hypercholesterolemia: Single Center ExperienceHulya Hacisahinogullari, Gamze Bilik Oyman, Ummu Mutlu, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 30, 2005
Liver transplantation for biliary atresia: 19-year, single-center experienceL Thomas Chin, Anthony M D'Alessandro, Stuart J Knechtle, et al.
Transplantation|January 1, 1992
The effect of donor age, recipient age, and HLA match on immunologic graft survival in cadaver renal transplant recipientsJ D Pirsch, A M D'Alessandro, H W Sollinger, et al.
Transplantation|February 27, 1995
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter TrialS V McDiarmid, R W Busuttil, N L Ascher, et al.
Surgery|October 1, 1992
Liver transplantation for alcoholic liver diseaseS J Knechtle, M F Fleming, K L Barry, et al.
Transplantation|April 1, 1993
Risk factors for primary dysfunction after liver transplantation--a multivariate analysisR J Ploeg, A M D'Alessandro, S J Knechtle, et al.
Clinical Transplants|January 1, 1989
Cadaveric renal transplantation in the cyclosporine and OKT3 eras: an update of the University of Wisconsin-Madison experienceA M D'Alessandro, D F Lorentzen, J D Pirsch, et al.
Transplantation Proceedings|April 26, 2005
Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimenS Florman, R Alloway, M Kalayoglu, et al.
Pageof 22